loading

Finanzdaten der Ekso Bionics Holdings Inc-Aktie (EKSO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
25.72%
3.14
4.227 2.057 3.375 4.95
Cost Of Revenue
12.46%
1.469
1.678 1.238 1.569 2.313
Gross Profit
34.44%
1.671
2.549 0.819 1.806 2.637
Operating Expenses
56.42%
6.18
3.951 4.794 5.246 4.972
Benefits Costs and Expenses
24.49
- - - -
Costs And Expenses
6.91%
6.018
5.629 6.032 6.815 7.285
Operating Income/Loss
221.61%
-4.509
-1.402 -3.975 -3.44 -2.335
Nonoperating Income/Loss
768.42%
-0.165
-0.019 1.266 0.549 -0.081
Income/Loss From Continuing Operations Before Tax
605.18%
-21.35
4.227 -2.709 -2.891 4.95
Income/Loss From Continuing Operations After Tax
228.92%
-4.674
-1.421 -2.709 -2.891 -2.416
Net Income/Loss
228.92%
-4.674
-1.421 -2.709 -2.891 -2.416
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
90.06%
0.26
2.616 2.18 25.39 18.22
Basic Earnings Per Share
188.89%
-1.56
-0.54 -1.24 -0.12 -0.13
Diluted Earnings Per Share
188.89%
-1.56
-0.54 -1.24 -0.12 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$66.75
price up icon 1.05%
$166.75
price down icon 0.01%
medical_instruments_supplies COO
$70.37
price down icon 1.60%
$75.27
price up icon 0.09%
medical_instruments_supplies WST
$235.15
price up icon 1.82%
$41.15
price up icon 0.44%
Kapitalisierung:     |  Volumen (24h):